NCT02094196View on ClinicalTrials.gov

The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2018

Study Completion Date

December 31, 2018

Conditions
Alcohol Use Disorder
Interventions
OTHER

Alcohol detoxification

Detoxified alcohol- dependent patients in an inpatient setting

Trial Locations (2)

10115

Charité Berlin, Division of Neuroimaging, Berlin

10117

Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

lead

Technische Universität Dresden

OTHER

NCT02094196 - The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders | Biotech Hunter | Biotech Hunter